Related Experiment Video
Updated: Feb 19, 2026
08:46
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
54.1K
Current state of CAR-T cell therapies for solid tumors.
Reginaldo Rosa1, Jiangyue Liu2, Cathy Lu1
1Department of Medicine, Division of Medical Oncology, Keck School of Medicine of USC, Los Angeles, CA 90033, USA.
Med (New York, N.Y.)
|February 17, 2026
Summary
Chimeric antigen receptor (CAR)-T cell therapy shows promise for solid tumors but faces challenges. Strategies like multi-antigen targeting and combination therapies are being developed to improve CAR-T cell efficacy against cancers.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Chimeric antigen receptor (CAR)-T cell therapy has revolutionized hematological cancer treatment.
- Significant obstacles hinder the application of CAR-T cell therapy in solid tumors.
Purpose of the Study:
- This review examines the current status of CAR-T cell therapy for solid tumors.
- It highlights challenges and explores strategies to enhance CAR-T cell efficacy.
Main Methods:
- Review of preclinical and clinical studies on CAR-T cell therapy for solid tumors.
- Analysis of strategies including multi-antigen targeting, combination therapies, and armored CAR-T cells.
Main Results:
- Solid tumor CAR-T cell therapy faces challenges like antigen heterogeneity and immunosuppressive microenvironments.
- Innovative strategies show encouraging advancements in overcoming these limitations.
Conclusions:
- Addressing intrinsic challenges is crucial for successful CAR-T cell application in solid tumors.
- Continued research into novel strategies is essential for advancing solid tumor CAR-T cell therapies.
Keywords:
CAR-T cellsantigen heterogeneityclinical trialscombination therapysynthetic engineeringtumor microenvironmentMore Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
2.0K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:21Stem Cell Therapy for Tissue Regeneration
4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K